We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
A Covid-19 klinikai kimenetelének súlyosságát nemcsak a pszichiátriai kórállapot, hanem a pszichiátriai gyógyszerelés is befolyásolja.
- Authors
GÁBOR, NADUBINSZKY; GABRIELLA, VONYIK; BÉLA, SZÉKÁCS
- Abstract
The disease process in psychiatric patients who contracted SARS-CoV-2 infection might become more severe because of their impaired general health, comorbidities and unhealthy lifestyle. However, among all psychiatric conditions statistically significant correlation with severe and lethal outcome have been found only in schizophrenia with possible association of multiple immune dysfunctions. While the antipsychotic clozapine used in treatment resistant schizophrenia seems to decrease the likelihood of recovery of patients who underwent COVID-19 infection, antidepressants treatment for major depression may result in more favourable outcome. Mainly the antidepressant fluvoxamine has been reliably found effective by inhibiting cytokine storms observed in some COVID-19 infected patients.
- Subjects
MENTAL illness drug therapy; LIFESTYLES; EVALUATION of medical care; COVID-19; SCHIZOPHRENIA; CONVALESCENCE; FLUVOXAMINE; AUTOIMMUNE diseases; SEVERITY of illness index; CLOZAPINE; MENTAL illness; ANTIPSYCHOTIC agents; COMORBIDITY
- Publication
Lege Artis Medicine (LAM), 2021, Vol 31, Issue 8/9, p357
- ISSN
0866-4811
- Publication type
Article
- DOI
10.33616/lam.31.027